Janssen, to close Hyangnam plant in Korea
By Lee, Tak-Sun | translator Choi HeeYoung
21.02.09 06:10:48
°¡³ª´Ù¶ó
0
Go through administrative procedures according to the technology transfer between Korea and Germany
¡ãJanssen Korea¡®s factory in Hyangnam
With the withdrawal of the Hyangnam factory this year, Janssen Korea is reorganizing its domestic product lineup of Tylenol and UltracetThe production of Tylenol 8 hours ER and Ultracet is undergoing a transition or shutdown procedure.
According to the MFDS on the 8th, all Ultracet products, an analgesic combination drug containing Tramadol-Acetaminophen, which were produced in the Hyangnam factory, were all converted for export. Accordingly, Ultracet produced at the Hyangnam Plant will soon end its insurance benefits.
Ultracet is largely divided into fast-acting tablet typed Ultracet, and sustained-release tablet typed Ultracet ER. It is also divided into Ultracet, Ultrac
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)